10-K/A: Minerva Neurosciences Files Amended 10-K to Correct Audit Firm Consent Date

Minerva Neurosciences has filed an amendment to its annual report to correct a typographical error in the date of the independent auditor's consent.

Summary

• Minerva Neurosciences filed an amendment to its annual report on Form 10-K to correct a typographical error.
• The error was in the date referenced in the consent of the independent registered public accounting firm, Deloitte & Touche, LLP.
• The original Form 10-K was filed on February 22, 2024, and this amendment was filed on February 23, 2024.
• The amendment includes a revised Exhibit 23.1 with the correct date.
• No other changes were made to the financial statements or other disclosures in the original Form 10-K.
• The company's common stock outstanding as of February 19, 2024, was 6,993,406 shares.
• The aggregate value of the company's common stock held by non-affiliates was approximately $36.9 million as of June 30, 2023.

Sentiment

Score: 7

Explanation: The document is a routine correction of a minor error, which is neither positive nor negative. The promptness of the correction is a positive sign.

Positives

• The company promptly corrected a typographical error in its filing.
• The amendment was limited to a single correction, indicating no broader issues with the original filing.

Management Comments

• Remy Luthringer, Ph.D., Executive Chairman and Chief Executive Officer, certified the accuracy of the amended report.
• Frederick Ahlholm, Chief Financial Officer, also certified the accuracy of the amended report.

Industry Context

This is a routine filing correction and does not indicate any significant industry trends or competitive issues.

Comparison to Industry Standards

• The correction of a typographical error in an SEC filing is a common occurrence across all industries.
• The promptness of the correction is consistent with good corporate governance practices.

Stakeholder Impact

• The correction ensures the accuracy of the company's filings, which is important for investor confidence.

Key Dates

Keywords

10-K, amendment, auditor consent, financial statements, Minerva Neurosciences, Deloitte & Touche, filing, SEC